Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Virginia Commonwealth University34 enrolled

Overview

Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Adherence, Patient

Interventions

Adherence monitoring and educationBEHAVIORAL

Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. 18 years or older 2. Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC \< 80% 3. Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor) Exclusion Criteria: 1. Patients who are enrolled in MedSync or Autorefill program 2. Patients who are lost to follow-up 3. Incomplete/missing documentation of an encounter 4. Prisoners, children

Locations (1)

Virginia Commonwealth University

Richmond, Virginia, United States

Outcomes

Primary Outcomes

Adherence in oral diabetes medications determined by star ratings

Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

Time frame: Baseline to 6 months

Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings

Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

Time frame: Baseline to 6 months

Secondary Outcomes

Change in proportion of days covered (PDC)

Determine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test.

Time frame: Baseline to 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.